By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile

 

Somaxon Pharmaceuticals, Inc. 

12750 High Bluff Drive, Suite 310

San Diego  California  92130  U.S.A.
Phone: 858-509-3670 Fax: 858-509-1589


SEARCH JOBS


Industry
Pharmaceutical

Segment
Research





Company News
Health Canada Approves Paladin Labs Inc. (CC:PLB) Silenor New Drug Submission 12/18/2012 7:30:09 AM
Somaxon Pharmaceuticals, Inc. (SOMX) Acquired by Pernix Therapeutics, Inc. (PTX) for $25 Million 12/11/2012 7:33:39 AM
Somaxon Pharmaceuticals, Inc. (SOMX) Reports Third Quarter 2012 Financial Results 11/1/2012 7:28:50 AM
Somaxon Pharmaceuticals, Inc. (SOMX) to Report Third Quarter 2012 Results and Conduct Conference Call on Wednesday, October 31 10/23/2012 9:03:43 AM
Somaxon Pharmaceuticals, Inc. (SOMX) Approves 1-for-8 Reverse Stock Split and Decrease in the Number of Authorized Shares of Its Common Stock to 25,000,000 Shares 10/11/2012 9:21:01 AM
Somaxon Pharmaceuticals, Inc. (SOMX) to Present at the Stifel Nicolaus 2012 Healthcare Conference 8/28/2012 9:24:10 AM
Somaxon Pharmaceuticals, Inc. (SOMX) Reports Second Quarter 2012 Financial Results 8/8/2012 9:56:13 AM
Somaxon Pharmaceuticals, Inc. (SOMX) to Report Second Quarter 2012 Results and Conduct Conference Call on Tuesday, August 7 7/30/2012 9:44:39 AM
Somaxon Pharmaceuticals, Inc. (SOMX) Completes $3.0 Million Registered Direct Offering 7/25/2012 9:19:55 AM
Somaxon Pharmaceuticals, Inc. (SOMX) to Raise $3.0 Million in Registered Direct Offering 7/20/2012 9:41:07 AM
12345678910...
//-->